FDA publishes discussion paper on AI/ML in drug development
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesMedical DevicesNorth AmericaPharmaceuticalsRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesMedical DevicesNorth AmericaPharmaceuticals